Publicaciones en colaboración con investigadores/as de Universidade da Madeira (29)

2019

  1. Effects of hydroxycinnamic acids on the glycolysis pathway

    South African Journal of Botany, Vol. 120, pp. 219-229

  2. Is it necessary to show virtual limbs in action observation neurorehabilitation systems?

    JOURNAL OF REHABILITATION AND ASSISTIVE TECHNOLOGIES ENGINEERING, Vol. 6

  3. Prediction of terpenoid toxicity based on a quantitative structure–activity relationship model

    Foods, Vol. 8, Núm. 12

2018

  1. A Small Molecule Tubulin Depolymerizing Agent Identified by a Phenotypic Drug Discovery Approach

    Journal of Molecular and Clinical Medicine, Vol. 1, Núm. 2, pp. 67-76

  2. Differential mechanism of action of the CK1ε inhibitor GSD0054

    Journal of Molecular and Clinical Medicine, Vol. 1, Núm. 2, pp. 77-83

2015

  1. Synthesis and identification of unprecedented selective inhibitors of CK1ε

    European Journal of Medicinal Chemistry, Vol. 96, pp. 308-317

2014

  1. Dual-stage triterpenoids from an African medicinal plant targeting the malaria parasite

    Bioorganic and Medicinal Chemistry, Vol. 22, Núm. 15, pp. 3887-3890

2013

  1. Discovery of a new small-molecule inhibitor of p53-MDM2 interaction using a yeast-based approach

    Biochemical Pharmacology, Vol. 85, Núm. 9, pp. 1234-1245

  2. Generation of artificial neural networks models in anticancer study

    Neural Computing and Applications, Vol. 23, Núm. 3-4, pp. 577-582

  3. Molecular docking studies of the interaction between propargylic enol ethers and human DNA topoisomerase IIα

    Bioorganic and Medicinal Chemistry Letters, Vol. 23, Núm. 19, pp. 5382-5384

  4. Sulfated small molecules targeting EBV in Burkitt lymphoma: From in silico screening to the evidence of in vitro effect on viral episomal DNA

    Chemical Biology and Drug Design, Vol. 81, Núm. 5, pp. 631-644

2012

  1. Dual inhibitors of P-glycoprotein and tumor cell growth: (Re)discovering thioxanthones

    Biochemical Pharmacology, Vol. 83, Núm. 1, pp. 57-68

  2. Enantioseparation and chiral recognition mechanism of new chiral derivatives of xanthones on macrocyclic antibiotic stationary phases

    Journal of Chromatography A, Vol. 1241, pp. 60-68

  3. Interaction of antimicrobial peptides, BP100 and pepR, with model membrane systems as explored by Brownian dynamics simulations on a coarse-grained model.

    Biopolymers, Vol. 98, Núm. 4, pp. 294-312

  4. Multidrug resistance reversal effects of aminated thioxanthones and interaction with cytochrome P450 3A4

    Journal of Pharmacy and Pharmaceutical Sciences, Vol. 15, Núm. 1, pp. 31-45

  5. Structure and Ligand-based design of P-glycoprotein inhibitors: A historical perspective

    Current Pharmaceutical Design, Vol. 18, Núm. 27, pp. 4197-4214

2011

  1. Comparative QSAR analyses of competitive CYP2C9 inhibitors using three-dimensional molecular descriptors

    Chemical Biology and Drug Design, Vol. 78, Núm. 1, pp. 112-123

  2. New uses for old drugs: Pharmacophore-based screening for the discovery of P-glycoprotein inhibitors

    Chemical Biology and Drug Design, Vol. 78, Núm. 1, pp. 57-72

2010

  1. Escherichia coli cell surface perturbation and disruption induced by antimicrobial peptides BP100 and pepR

    Journal of Biological Chemistry, Vol. 285, Núm. 36, pp. 27536-27544

  2. Insights into the in vitro antitumor mechanism of action of a new pyranoxanthone

    Chemical Biology and Drug Design, Vol. 76, Núm. 1, pp. 43-58